Comparison between Roche Integra 400 plus and Abbott Architect ci8200 in Alanine aminotransferase assay

The aim of this work is to present the results of a comparative study between the ALT assay on Integra 400 plus Roche Diagnostic versus Architect ci8200 of Abbott Diagnostic. A total of 200 patients hospitalized in the various departments of the university hospital Mohammed VI of Oujda were prospect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Practical laboratory medicine 2019-05, Vol.15, p.e00121-e00121, Article e00121
Hauptverfasser: Lamrabat, Somiya, Lyagoubi, Amina, Bouayadi, Ouardia, Elmalki, Jalila, Elkouche, Khadija, Bensalah, Mohammed, Choukri, Mohammed
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The aim of this work is to present the results of a comparative study between the ALT assay on Integra 400 plus Roche Diagnostic versus Architect ci8200 of Abbott Diagnostic. A total of 200 patients hospitalized in the various departments of the university hospital Mohammed VI of Oujda were prospectively tested on two systems: Abbott Architect ci8200 and Roche Integra 400 plus. Both analyzers use the spectrophotometric technique by coupling the transamination reaction to the oxidation-reduction reaction at NAD. The agreement of the results between the different techniques was evaluated using the Bland-Altman difference diagram and the Passing-Bablok and Deming regression line. There was a high concordance between the two assays: the equation of the Passing-Bablok line is YArchitect ​= ​−0,5625 ​+ ​0,9917 XIntegra with a correlation coefficient r2 = 0.999. The Bland-Altman diagram shows that the mean bias between the two methods is of the order of 1.1 IU/L and the difference between the ALT measurements by Architect and Integra is in the range of −1.4 to 3.6. Our study shows a high correlation of the ALT assay results between the architect ci8200 and Integra 400 plus.
ISSN:2352-5517
2352-5517
DOI:10.1016/j.plabm.2019.e00121